Hematopoiesis
Hematopoiesis is the formation of blood cells. It starts during embryonic development and continues throughout adulthood to produce and replenish the blood cellular components. Hematopoiesis either medullary (occurred in the bone marrow) or extramedullary (other than bone marrow) depending on the age of the individuals.
The sites of extramedullary hematopoiesis are the yolk sac, liver, spleen, kidney, and adrenals. During the early stage of embryonic development, the hematopoiesis is mainly extramedullary, but during the late stage of gestation and soon after birth the hematopoiesis occurs in the bone marrow. In adulthood, extramedullary hematopoiesis can occur in individuals suffering from hematological disorders.4.2.1 Pluripotential Hematopoietic Stem Cells (PHSC)
These cells are characterized by their long self-renewal capacity and pluripotency. PHSC have the capability to undergo mitotic cell divisions and a portion of these cells remain undifferentiated and maintain a constant pool of PHSC throughout life whereas another portion of PHSC is programmed for differentiation to produce specialized cells. The term pluripotency denotes the ability to differentiate into the cells of a particular lineage. The predominant source of PHSC is the bone marrow (1 in every 100,000 cells in the marrow are PHSC), but they can mobilize the circulation and a substantial number of PHSC are available in peripheral blood. Beside these, PHSC are found in umbilical cord blood, fetal hematopoietic system (yolk sac and fetal liver) and embryonic stem cells and embryonic germ cells. PHSCs migrate to the bone marrow just before birth where they permanently reside throughout life. In human, long bones are the primary site for medullary hematopoiesis up to 20 years of age. Later, the medullary hematopoiesis occurs at flat bones like sternum and vertebrae.
The clinical uses of PHSC include the treatment of leukemia and lymphoma and inherited blood disorders like sickle cell anemia, autoimmune disorders and to replenish damaged cells during cancer chemotherapy.The hematopoiesis can be broadly classified into two categories based on their time of occurrence and the nature of the precursors and progenitor cells. The primitive wave of erythropoiesis mostly seen during embryonic/fetal life in fetal hematopoietic systems characterized by generation of large, nucleated erythrocytes including macrophages and megakaryocytes. The primitive wave is transient and the erythroid progenitors thus produced are neither pluripotent nor having self-renewal property. In contrast, definitive wave is characterized by the development of all blood cell lineages from hematopoietic stem cells occurred during later stage of development. However, there is a transient definitive wave of hematopoiesis that occurs in most of the species produces erythroid-myeloid progenitors (EMPs).
4.2.2 Development of Pluripotential Hematopoietic Stem Cells
All the blood cells are derived from the mesodermal germ layer. The dorsal mesoderm gives rise to somites and notochord, whereas the ventral mesoderm is specified for blood and vasculature. The exact mechanism behind the differentiation of the mesodermal germ layer into hematopoietic stem cells is still awaiting clarification. In humans, hematopoiesis starts around day 17 of embryonic life in the yolk sac. During the course of prenatal development, the site of hematopoiesis varies considerably. The first hepatic colonization of hematopoietic site occurs around day 23 which then migrates to arterial colonization (day 27), second hepatic colonization (day 30), and finally bone marrow colonization around the 11th week of prenatal development.
4.2.3 Development of Progenitor Cells
The first primitive wave of fetal erythropoiesis occurred in the blood island of extra-embryonic yolk sac from a cluster of early endothelial cells (hemangioblast) gives rise to a large nucleated erythroid progenitor along with macrophages and rare megakaryocyte progenitors.
The purpose of this primitive wave is to generate red blood cells for tissue oxygenation of a rapidly growing embryo.A second definitive wave of hematopoiesis occurs in the fetal liver from long-term hematopoietic stem cells (LT-HSC) and generates more complex functionally competent adultlike blood cells. This wave also favors the third wave of hematopoiesis. LT-HSC are having self-renewal properties and are differentiated into short-term hematopoietic stem cells (ST-HSC), which undergoes further differentiation into common myeloid progenitors (CMP) or colony forming unit granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM), and common lymphoid progenitor (CLP). CMP generates megakaryocyte, erythroid, granulocytes, and macrophages progenitors and CLP give rise to B and T lymphocytes.
The third wave of hematopoiesis occurs in the aorta-gonad- mesonephros (AGM) region of the developing embryo from autonomously generated first adult PHSCs, giving rise to the permanent adult hematopoietic system. The stages are almost similar with second wave of hematopoiesis.
4.2.4 Erythropoiesis
The genesis of erythrocytes from PHScs through series of proliferation and differentiation is called erythropoiesis. The erythropoiesis is aimed either to replenish old and damaged RBCs (basal erythropoiesis) or to cope up the hypoxia due to blood loss or anemia (stress-induced erythropoiesis).
4.2.4.1 Formation of Erythroid Progenitor Cells and Erythroid Precursor Cells
The earliest erythroid progenitor developed from CMP is burst forming unit-erythroid (BFU-E) followed by colony forming units-erythroid (CFU-Es). These erythroid progenitor cells undergo differentiation to form erythroid precursor cells termed as proerythroblast/rubriblast/pronormoblast; however, rubriblast is used as a veterinary terminology. These rubriblasts are characterized by basophilic cytoplasm along with centrally located nuclei with deeply stained chromatin granules. The rubriblasts then undergo a series of differentiation characterized by decrease in cell size with gradual increase in hemoglobin content followed by condensation of nuclear chromatin.
The stages next to rubriblasts are prorubricytes which lack nucleus. From prorubricytes, the subsequent developmental stages are basophilic rubricytes/ basophilic erythroblasts, polychromatophilic rubricytes/ erythroblasts, and metarubricytes/orthochromatophilic erythroblasts. These stages are characterized by increasing hemoglobin content. Metarubricytes have higher hemoglobin content followed by polychromatophilic rubricytes and basophilic rubricytes.4.2.4.2 Terminal Erythropoiesis: Enucleation and Organelle Clearance
Maturation of committed erythroid precursors to form reticulocytes is called terminal erythropoiesis. The terminal erythropoiesis involves some morphological alteration such as reduction in cell size, chromatin condensation, production of hemoglobin, and finally enucleation and elimination of cytosolic organelle such as Golgi apparatus, endoplasmic reticulum, mitochondria, and ribosomes. In early mammalian embryo, enucleation occurs at the fetal liver whereas from mid gestation and during adulthood the principal site of enucleation is the bone marrow. The erythroblastic island of the bone marrow consists of a central macrophage surrounded by erythroblasts and the interaction between macrophage and erythroblasts is essentially required for differentiation of erythroblasts.
The preparatory phages prior to enucleation include arrest in the cell cycle, chromatin condensation, and nuclear polarization. The enucleation process is facilitated by rearrangement of specific surface antigens that make erythroid cells prone to macrophage engulfment.
The removal of cell organelle is facilitated by the process of autophagy, characterized by the formation of the autophagosome, its fusion with the lysosome to form phagolysosome, and finally the degradation of organelles by hydrolytic enzymes.
4.2.4.3 Factors Affecting Erythropoiesis
4.2.4.3.1 Tissue Oxygenation: Role of Erythropoietin
Tissue oxygenation is the primary stimulus for erythropoiesis.
Hypoxia-induced erythropoiesis is mediated through erythropoietin (EPO). EPO is a polypeptide (MW 34000) composed of 139 amino acid residues. During embryonic life, EPO is produced from fetal liver where it acts like paracrine-endocrine manner as liver is the site of erythropoietin synthesis as well as erythropoiesis. Later the site of EPO secretion switches from liver to kidney (mesangial cells, tuft of glomeruli, and renal tubular epithelium) and small amount from liver. During adult life, 90% of EPO is produced from the kidney. After secreted from kidney or liver, EPO reaches in the bone marrow through peripheral circulation to exert its effect. The secretion of EPO in response to hypoxia is brought about by a cellular oxygen sensor named hypoxiainducible transcription factor-1 (HIF-1).EPO acts through EPO receptor (EPO-R) expressed primarily on erythroid progenitor cells like BFU-E and colony forming units-erythroid (CFU-E) though their number varies on the basis of differentiation stages. The signal transduction pathway after activation of EPO-R increases calcium influx inside the cell which in turn regulates expression of protooncogenes, phosphorylation of transcriptional factors, or activation of calcineurin and ultimately favors the growth, survival, and differentiation of erythroid committed progenitor cells for the production of proerythroblasts/rubriblasts or by decreasing the rate of apoptosis.
4.2.4.3.2 Nutrition: Iron, Vitamin-B12 and Folic Acid
The nutritional status of the animals, particularly, iron, Vita- min-B12, and folic acid are essentially required for erythropoiesis, and thus the deficiency of these factors leads to nutritional anemias.
Iron forms the nucleus of the iron-porphyrin heme ring and is required for hemoglobin synthesis. Iron deficiency leads to insufficient hemoglobin formation and microcytic erythrocytes (small size).
Two vitamins, namely vit-B12 and folic acid, are required for the maturation of RBC.
Vit B12 and folic acid are important for the formation of thymidine triphosphate, one of the essential building blocks of DNA. The lack of these vitamins leads to formation of erythrocytes with flimsy membrane and irregular shape as well as apoptosis of erythroid cells. After entering into the circulation, the cells are rapidly destroyed due to their poor fragility.Intrinsic factor (IF), a glycoprotein released from parietal cells, helps in absorption of vit-B12 by protecting it from gastric digestion. Lack of intrinsic factor causes loss of vit-B12 by the action of digestive enzymes and failure of its absorption.
Vitamin-C helps in iron absorption either by preventing the formation of insoluble and unabsorbable iron compounds and/or by the reduction of ferric to ferrous iron required for the iron uptake into the mucosal cells.
4.2.5 Leukopoiesis
Leukopoiesis is the development of leukocytes. PHSCs are differentiated into common myeloid progenitors (CMP) or colony forming unit granulocyte, erythrocyte, monocyte, megakaryocyte (CFU-GEMM), and common lymphoid progenitor (CLP). CMP generates megakaryocyte, erythroid, granulocytes, and macrophages progenitors and CLP give rise to B and T lymphocytes. CFU-GEMM differentiated into granulocyte-monocyte progenitor (GMP) cells which ultimately give rise to granulocytes or monocytes. CFU eosinophils (CFU-Eo) and basophils (CFU-Ba) differentiated to form eosinophils and basophils.
4.2.5.1 Granulopoiesis and Monocytopoiesis
The granulopoiesis is the development of granulocytes and monocytopoiesis is the development of monocytes. Myeloblast is the first granulocyte precursor which is differentiated into promyelocytes. Up to promyelocyte stage, the granulocyte and monocyte cell lines are similar then the cell lines develop cell lineage-specific granules and form neutrophil myelocyte, eosinophil myelocyte, and basophil myelocyte. The myelocytes then undergo differentiation to form neutrophil metamyelocyte and eosinophil metamyelocyte. Polymorphonuclear basophils are developed from basophil myelocyte. However, neutrophil and eosinophil myelocytes undergo another differentiation step called neutrophil and eosinophil meta-myelocytes. The neutrophils have one additional stage of development called “band” neutrophil metamyelocyte before the final stage, i.e., polymorphonuclear neutrophils. The granules are developed successively during the course of development. The nucleated granules are developed during early pro-myelocyte stage. Azurophil granules are developed during late promyelocyte stage and specific granules are formed during myelocyte stage. The granulocyte precursors can be divided into two pools. The proliferation pool consists of the cells that can be divided into myeloblasts, promyelocytes, and myelocytes. The metamyelocytes and band cells are unable to be divided and categorized under maturation pool. The storage pool is the subdivision of maturation pool which stores mature neutrophils. The storage pool is large in dogs but small in ruminants.
The first monocyte precursor cells developed from GMP are monoblasts which undergo differentiation to form promonocytes and monocytes. In contrast to granulocytes, monocytes don’t have any storage pool, but they enter venous sinusoids and migrate to the tissue where they are differentiated into macrophages.
4.2.5.2 Development of Lymphocytes
The development of lymphocytes occurs in the central/pri- mary lymphoid organs (bone marrow or fetal liver) and thymus for B and T lymphocytes, respectively. The lymphocytes produced in the primary lymphoid organs are then migrated to peripheral lymphoid organs/secondary lymphoid organs where they interact with the antigens. In adults, the development of T cells in the thymus is decreased, but a continual supply is maintained through division of mature T cells in the peripheral lymphoid organs. In contrast, B cells are produced continuously from the bone marrow in adults. The common lymphoid progenitor (CLP) differentiated into pro-B and pro-T cells which give rise to B and T lymphocytes, respectively.
The antigenic specificity of B and T cells is marked by the immunoglobulins and T cell receptor (TCR), respectively. The differentiation of lymphocytes therefore required genetic programming to express immunoglobulin or TCR, respectively, for B and T lymphocytes. The genes responsible for antigen receptors in B cells (immunoglobulin) and T cells (TCR) undergo specific arrangement of variable (V), diversity (D), and joining (J) regions of the gene segment through a process called V (D) J recombination. The V (D) J recombination is a process of selecting V, (D), and J chains in lymphocyte and arranging it into a single exon and generate a novel amino acid sequence for the antigen-binding regions (V regions) for immunoglobulins and TCR. The successful assembly is called a productive rearrangement and is monitored in each developmental stages and acts as a signal to progress into the next stage.
4.2.5.2.1 B Lymphocyte Development
In the bone marrow, CLP differentiated into pro-B cells without the antibody expression. The V (D) J recombination for immunoglobulins starts during this stage due to expression of recombination activating gene (Rag gene). The pro-B cells differentiated into pre-B cells once the V (D) J recombination for heavy chains is completed. In pre-B stage, the V (D) J recombination for light chains starts and once it is completed the pre-B cells are transformed to immature B cells. The immature B cells express IgM. The immature B cells then undergo negative selection to test its reactivity against self-antigens. The auto-reactive B cells either undergo apoptosis through a process called clonal deletion or there is reactivation of Rag for light chain receptor editing. The mature B cells thus ultimately produce and migrate to secondary lymphoid organs and express both IgM and IgD molecule. The time required to form mature B cells from hematopoietic stem is usually 1-2 weeks.
4.2.5.2.2 T Lymphocyte Development
The precursors of T lymphocyte are pro-T cells. Pro-T cells are differentiated into pre-T cells after V (D) J recombination of β chain of TCR. The pre-T cells express only β chain and further differentiate to form double positive T cells with both α and β chain along with CD4 and CD8 over their surface. Then they undergo positive and negative selection to form mature T cells.
4.2.6 Thrombopoiesis
The precursors of the platelets are megakaryocytes derived from bi-potent common myeloid progenitors (CMP) for both erythrocytes and platelets. CMP can be detected in the yolk sac of mouse embryo as early as day (E) 10.5. CMP differentiated into megakaryocyte colony forming cells (Meg-CFCs) with fetal liver by day (E) 11.5 which is the predominant source of megakaryocyte progenitor that produce platelets of larger size with less cytoplasmic granules. Megakaryocytes undergo nuclear endomitosis (DNA replication without cell division), disassembling of centrosomes and the translocation of microtubules to cell cortex and forms broad pseudopodia to become proplatelets in which the nucleus is extruded. A megakaryocyte can give rise to 10-20 proplatelets which protrude from megakaryocytes. The maturation of megakaryocytes to platelets required around 5 days in human and 2-3 days in rodents. Platelets may survive in blood stream for 7-10 days in human and 4-5 days in rodents.
4.3